Infection rate in Guangzhou after easing the zero-COVID policy: seroprevalence results to ORF8 antigen

Lancet Infect Dis. 2023 Apr;23(4):403-404. doi: 10.1016/S1473-3099(23)00112-3. Epub 2023 Feb 17.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / epidemiology
  • Humans
  • SARS-CoV-2
  • Seroepidemiologic Studies
  • Viral Proteins

Substances

  • Viral Proteins